Immediate Impact
51 standout
Citing Papers
Improved cytosine base editors generated from TadA variants
2023 Standout
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616
2023 Standout
Works of Razvan T. Dadu being referenced
Lipid lowering with PCSK9 inhibitors
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Razvan T. Dadu | 112 | 172 | 59 | 68 | 15 | 391 | |
| Svetlana Moșteoru | 77 | 195 | 57 | 48 | 13 | 368 | |
| Marc-André Lavoie | 74 | 189 | 42 | 91 | 12 | 377 | |
| Raimundo de Andrés | 135 | 213 | 38 | 53 | 20 | 404 | |
| Curtis Rambaran | 169 | 237 | 28 | 53 | 18 | 414 | |
| Elsa Valdés‐Márquez | 84 | 162 | 39 | 65 | 19 | 439 | |
| Paymon Azizi | 126 | 88 | 77 | 90 | 18 | 386 | |
| Krzysztof Dyrbuś | 214 | 277 | 41 | 40 | 20 | 456 | |
| Martina F Mohrschladt | 134 | 174 | 146 | 70 | 8 | 392 | |
| Xin Liu | 105 | 114 | 34 | 130 | 22 | 391 | |
| Michał Tomaszewski | 85 | 124 | 55 | 108 | 28 | 430 |
All Works
Login with ORCID to disown or claim papers
Loading papers...